share_log

LevelJump Provides Business Update; Reflection on 2023 Accomplishments & Planned Growth for 2024

LevelJump Provides Business Update; Reflection on 2023 Accomplishments & Planned Growth for 2024

LevelJump 提供業務最新情況;對 2023 年成就和 2024 年計劃增長的反思
newsfile ·  02/16 06:58
  • JUMP expects to announce over a 30% year-over-year increase in revenue for its wholly owned subsidiary, Canadian Teleradiology Services ("CTS").1
  • In 2023, JUMP became a nation-wide Company with operations spanning three different provinces in Canada.
  • JUMP預計將宣佈其全資子公司加拿大遠程放射服務公司(“CTS”)的收入同比增長30%以上。1
  • 2023 年,JUMP 成爲一家全國性公司,業務遍及加拿大的三個不同省份。

Toronto, Ontario--(Newsfile Corp. - February 16, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTC Pink: JMPHF) (FSE: 75J) ("LevelJump" or the "Company"), a Canadian leader in B2B telehealth solutions, is pleased to announce an update of its 2023 accomplishments and upcoming 2024 developments.

安大略省多倫多--(Newsfile Corp.,2024年2月16日)——加拿大B2B遠程醫療解決方案領導者LevelJump Healthcare Corp.(多倫多證券交易所股票代碼:JUMP)(FSE:75J)(“LevelJump” 或 “公司”)很高興地宣佈其2023年成就和2024年即將到來的發展的最新情況。

Doubling of JUMP's IHF Footprint

JUMP 的 IHF 足跡翻了一番

On October 6, 2023, JUMP completed the acquisition of four Alberta-based Diagnostic Imaging Clinics offering multi-modality imaging to local communities in Calgary. Since the acquisition, the Company has been working vigorously to streamline operations, increase revenues at all locations and elevate the overall patient experience.

2023年10月6日,JUMP完成了對四家位於艾伯塔省的診斷成像診所的收購,這些診所爲卡爾加里當地社區提供多模態成像。自收購以來,該公司一直在努力簡化運營,增加所有地點的收入並改善整體患者體驗。

"In 2023, JUMP strategically focused on acquisitions and modernizing operations in existing and newly acquired clinics," said CEO, Mitch Geisler. "With a commitment to boosting revenue and increasing shareholder value, the Company is forging ahead, establishing an efficient operational framework for sustained growth and success in the evolving market landscape."

首席執行官米奇·蓋斯勒表示:“2023年,JUMP的戰略重點是收購現有和新收購的診所並實現運營現代化。”“公司致力於增加收入和增加股東價值,正在向前邁進,建立有效的運營框架,以在不斷變化的市場格局中實現持續增長和成功。”

JUMP's Yonge-Sheppard Flagship Clinic

JUMP 的 Yonge-Sheppard 旗艦診所

Located at the central, high-foot-traffic location of the Yonge Sheppard Centre, JUMP's highly anticipated flagship clinic is expected to open Q2 2024. Following the acquisition of the license in December of 2022, the Company has spent 2023 developing the multi-modality clinic, ensuring its readiness to it to provide patients with high-quality x-ray and ultrasound services.

JUMP備受期待的旗艦診所位於揚格·謝潑德中心的中心人流量大,預計將於2024年第二季度開業。繼2022年12月獲得許可證後,該公司花了2023年開發多模式診所,確保爲患者提供高質量的X射線和超聲波服務做好準備。

Beyond the initial focus on diagnostic imaging, JUMP has plans to expand the Yonge Sheppard location, establishing it as the first location for in-person Telehospital care, providing primary physician care. The clinic's central location, accessible via two subway lines, guarantees not only high visibility but also ensures convenience for Toronto residents seeking accessible healthcare.

除了最初專注於診斷成像外,JUMP還計劃擴建Yonge Sheppard分支機構,將其建成第一個提供初級醫生護理的面對面遠程醫院護理地點。該診所的中心位置可通過兩條地鐵線到達,不僅保證了高能見度,而且還確保了尋求無障礙醫療服務的多倫多居民的便利。

Telehospital Web Development

遠程醫院 Web 開發

In 2023, the Company began the development of teleHospital Canada in partnership with 247 Labs Inc, an award-winning team of experienced web and mobile app developers. The digital health platform will provide remote urgent care and emergency room consultation services to Canadians, in hopes of marking a significant step towards revolutionizing healthcare accessibility and convenience.

2023年,該公司開始與247 Labs Inc合作開發加拿大遠程醫院,這是一支由經驗豐富的網絡和移動應用程序開發人員組成的屢獲殊榮的團隊。該數字健康平台將爲加拿大人提供遠程緊急護理和急診室諮詢服務,希望標誌着朝着徹底改變醫療保健的可及性和便利性邁出重要一步。

Scheduled for launch in the coming year, this innovative platform aligns with the Company's vision of leveraging technology to enhance and extend vital healthcare services to a broader population.

該創新平台計劃於來年推出,符合公司的願景,即利用技術來增強和擴展重要的醫療保健服務,使其惠及更多人群。

The Company is expecting to launch the BETA site in Q2 2024. To sign up for on-going updates, click here.

該公司預計將在2024年第二季度推出測試版網站。要註冊接收持續更新,請單擊此處。

Expansion of Teleradiology Services Beyond Ontario

將遠程放射學服務擴展到安大略省以外的地區

In September of 2023, the Company achieved a significant milestone by extending its Teleradiology services beyond Ontario, into Saskatchewan. The expansion reflects the strategic vision of CTS (JUMP's wholly owned operating subsidiary) which not only added on more client hospitals in 2023, but is actively pursuing new client acquisitions for the ongoing year.

2023 年 9 月,該公司將其遠程放射學服務擴展到安大略省以外的地區,延伸到薩斯喀徹溫省,從而實現了一個重要的里程碑。此次擴張反映了CTS(JUMP的全資運營子公司)的戰略願景,該公司不僅在2023年增加了更多的客戶醫院,而且正在積極尋求連續一年的新客戶收購。

As part of this growth strategy, CTS aims to further solidify its presence in the healthcare sector, enhancing its network of client hospitals beyond the current scope through its commitment to innovation and efficiency. CTS presently serves as the largest Teleradiology company in Canada, reflecting a substantial footprint that positions the Company as an upcoming key player in providing essential healthcare services across the region.

作爲該增長戰略的一部分,CTS旨在通過對創新和效率的承諾,進一步鞏固其在醫療保健領域的影響力,在當前範圍之外增強其客戶醫院網絡。CTS目前是加拿大最大的Teleradiology公司,這反映了其龐大的業務版圖,使該公司成爲該地區即將成爲提供基本醫療服務的關鍵參與者。

Looking ahead, the Company remains dedicated to expanding its reach, creating new partnerships, and providing healthcare solutions to hospitals and clinics across Canada.

展望未來,該公司將繼續致力於擴大其覆蓋範圍,建立新的合作伙伴關係,併爲加拿大各地的醫院和診所提供醫療保健解決方案。

Update on Settlement with Real Time Medical ("RTM")

與即時醫療(“RTM”)結算的最新情況

Further to its news release of August 30, 2023, the Company wishes to announce that it has entered into a revised settlement agreement with RTM whereby RTM has agreed to purchase the Company's interest in RTM in exchange for forgiveness of a shareholder loan and the discontinuance of an oppression claim brought by the Company against RTM and its directors in Ontario Superior Court (CV-22-683214-00CL).

繼2023年8月30日發佈的新聞稿之後,公司希望宣佈,它已與RTM簽訂了修訂後的和解協議,根據該協議,RTM同意購買公司在RTM的權益,以換取股東貸款的豁免,並終止公司在安大略省高等法院對RTM及其董事提出的壓制索賠(CV-22-683214-00CL)。

The settlement agreement originally provided that RTM would pay the Company $1,084,000 in cash by January 15, 2024. Under the revised settlement agreement, the Company will now receive total cash of $1,184,000 of which $200,0000 has been received, $100,000 is due on February 28, 2024 and the balance of $884,000 is due on April 30, 2024. In the event of default by RTM, the Company shall be entitled to obtain default judgement.

和解協議最初規定,RTM將在2024年1月15日之前向公司支付108.4萬美元的現金。根據修訂後的和解協議,公司現在將獲得總額爲11.84萬美元的現金,其中20萬美元已到期,10萬美元將於2024年2月28日到期,88.4萬美元的餘額將於2024年4月30日到期。如果RTM違約,公司有權獲得違約判決。

Update on Non-Brokered Private Placement

非經紀私募股權最新情況

The Company also wishes to announce that, following receipt of Exchange approval, and further to its news releases dated November 28, 2023, and January 17, 2024, there have been no further closings under the Company's now closed private placement.

該公司還希望宣佈,在獲得交易所批准後,繼其2023年11月28日和2024年1月17日發佈的新聞稿之後,公司現已封閉的私募沒有進一步的收盤。

Footnotes:

腳註:

  1. Based on preliminary financial information and subject to LevelJump's year end audit which is expected to be completed in April 2024.
  1. 基於初步財務信息,並以LevelJump的年終審計爲準,該審計預計將於2024年4月完成。

About LevelJump Healthcare

關於 LevelJump

LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.

LevelJump Healthcare Corp.(多倫多證券交易所股票代碼:JUMP)通過其遠程放射學部門爲客戶醫院和成像中心提供遠程醫療解決方案,並通過其診斷中心提供面對面的放射學服務。JUMP主要專注於急診和急診患者的重症監護,在我們服務的社區中建立完整的關係。

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

代表董事會
LEVELJUMP 醫療保健公司

Mitchell Geisler
Chief Executive Officer

米切爾·蓋斯勒
首席執行官

Caitlin-Robyn Densmore
Investor Relations Manager
Caitlin.Densmore@leveljumphealthcare.com
(437) 214-1568

Caitlin-Robyn Densmore
投資者關係經理
Caitlin.Densmore@leveljumphealthcare.com
(437) 214-1568

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

關於前瞻性信息的警示聲明

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

本新聞稿包含與公司業務計劃和公司行業前景有關的適用證券法所指的 “前瞻性信息”。儘管根據其高管和董事的經驗、當前狀況和預期的未來發展以及其他被認爲適當的因素,公司認爲,這些前瞻性信息中反映的預期是合理的,但不應過度依賴這些期望,因爲公司無法保證這些預期會被證明是正確的。實際結果和發展可能與這些陳述所設想的結果和進展存在重大差異。本新聞稿中的聲明自本新聞稿發佈之日起作出,除適用的證券法要求外,公司不承擔任何責任對其進行更新或修改以反映新的事件或情況。公司沒有義務評論第三方對公司、Canadian Teleradiology Services, Inc.、其證券或各自的財務或經營業績(如適用)的分析、預期或聲明。

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

交易所及其監管服務提供商(該術語在聯交所政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.

所發行的證券過去和將來都不會根據經修訂的1933年《美國證券法》(“美國證券法”)或任何美國州證券法進行註冊,也不得在美國發行或出售,也不得向沒有註冊或未獲得《美國證券法》和適用的美國州證券法註冊要求的適用豁免的美國人發行或出售。本新聞稿不構成在美國或其他任何司法管轄區出售證券的要約或要約購買證券。


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論